31 unknown. 31 Phase 2, 8 Phase 1, 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 31 | Unknown 31 |
| Phase 1 | 8 | Unknown 8 |
| Phase 3 | 6 | Unknown 6 |
Follow Control: new trials by email Literature Review of Control trials Research Report on Control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease Adalimumab-680LT, Control - Crohn Disease, Ulcerative Colitis | Phase 1 / Phase 2 | Unknown | University Medical Center Groningen | 21 | 2024-03-01 | 2024-03-12 |
| A Comprehensive Fall Prevention System for Memory Care: Final Feasibility and Randomized Controlled Study SafelyYou, Control - Dementia | Phase 2 | Unknown | SafelyYou | 300 | 2023-10-31 | 2022-05-09 |
| The Use of Steri3X for Prevention of Post-operative Wound Infections in Cesarean Sections Steri3X, Control - Surgical Site Infection, Cesarean Section; Complications, Wound, Infection (Following Delivery) | Phase 2 | Unknown | University of Tennessee | 1000 | 2023-02-07 | 2023-02-13 |
| Relationship Between Serum Vitamin D and Outcomes of Liver Transplantation in Cirrhotic Patients Undergoing Liver Transplantation and Effects of Vitamin D Supplementation in Post-transplant Period vitamin D supplementation, control - Liver Transplant; Complications, Vitamin D Deficiency | Phase 1 / Phase 2 | Unknown | National Nutrition and Food Technology Institute | 42 | 2022-11-01 | 2022-10-07 |
| Treating Heart Failure With hiPSC-CMs hiPSC-CM therapy, Control - Heart Failure | Phase 1 / Phase 2 | Unknown | HELP Therapeutics Co., Ltd. | 20 | 2022-06-30 | 2023-11-22 |
| Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX Neulapeg, Control - Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | Phase 2 | Unknown | Yonsei University | 78 | 2022-02-16 | 2024-04-09 |
| Improving Tumor Treating Fields Treatment for Brain Cancer Patients With Skullremodeling Surgery (Neurosurgery) Skullremodeling surgery, Control - Recurrent Glioblastoma | Phase 2 | Unknown | Anders Rosendal Korshøj | 70 | 2020-10-01 | 2023-06-06 |
| High Flow Nasal Cannula Oxygen During Sedation for Video-assisted Thoracoscopic Surgery High flow nasal cannula, CONTROL - Chronic Obstructive Pulmonary Disease, Respiratory Failure | Phase 2 | Unknown | Alexandria University | 60 | 2020-08-01 | 2020-08-20 |
| Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus lenvatinib, Placebo - Hepatocellular Carcinoma, Portal Vein Tumor Thrombus | Phase 2 / Phase 3 | Unknown | RenJi Hospital | 108 | 2020-05-02 | 2020-03-24 |
| Efficacy of Antiresorptive and Bone Forming Material on Dental Implants ALN Gel, BMP Gel, Mixed Gel - Partial Edentulism | Phase 1 / Phase 2 | Unknown | University of Baghdad | 20 | 2019-07-01 | 2019-10-25 |
| A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes Mellitus GX-G6, Control - Type 2 Diabetes Mellitus | Phase 2 | Unknown | Genexine, Inc. | 78 | 2019-06-01 | 2019-05-23 |
| BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients BM-MNC and UC-MSC, Control - Type 2 Diabetes Mellitus | Phase 1 / Phase 2 | Unknown | Van Hanh General Hospital | 60 | 2019-04-24 | 2019-05-10 |
| Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO Inhaled Nitric Oxide, Placebo - Anemia | Phase 1 / Phase 2 | Unknown | New York Medical College | 50 | 2019-02-06 | 2019-04-24 |
| Effects on Lipid Metabolism of Olive Extracts Rich in Polyphenols Olive polyphenols, Control - Cholesterol; Metabolic Disorder, Metabolic Syndrome | Phase 2 | Unknown | Universidad Miguel Hernandez de Elche | 60 | 2018-06-01 | 2018-07-12 |
| Topical Bimatoprost in the Treatment of Migraine Bimatoprost Topical Solution, Control - Migraine Disorders, Headache Disorders | Phase 2 | Unknown | Manistee Partners | 70 | 2018-01-05 | 2019-04-26 |
| Prophylactic Tamsulosin in Prevention of Post-operative Urinary Retention in Men After Transanal Endoscopic Microsurgery Tamsulosin Hydrochloride 0.4 MG, Placebo oral capsule, Foley catheter - Urinary Retention | Phase 2 | Unknown | CHU de Quebec-Universite Laval | 158 | 2017-10-06 | 2021-05-19 |
| Efficacy of Allogeneic Umbilical Cord Derived Hematopoietic and Mesenchymal Stem Cells in Cerebral Palsy MNC, MSC, Control - Cerebral Palsy, Spastic | Phase 2 | Unknown | Tehran University of Medical Sciences | 108 | 2017-07-23 | 2019-01-08 |
| Somatosensory Stimulation in Knee Osteoarthritis Somatosensory electrical stimulation, Control - Osteoarthritis, Knee | Phase 2 | Unknown | Menno Veldman | 20 | 2016-09-01 | 2016-08-03 |
| Study of Cavosonstat (N91115) in CF Patients Who Are Heterozygous for F508del-CFTR and a Gating Mutation and Being Treated With Ivacaftor Cavosonstat, Placebo - Cystic Fibrosis | Phase 2 | Unknown | Nivalis Therapeutics, Inc. | 19 | 2016-04-01 | 2016-11-21 |
| To Evaluate the Safety and Efficacy of IM and IV Administration of Autologous ADMSCs for Treatment of CLI Autologous Stromal Vascular Fraction (SVF), Autologous Adipose Derieved MSCs, Control - Critical Limb Ischemia | Phase 1 / Phase 2 | Unknown | Kasiak Research Pvt. Ltd. | 60 | 2014-08-01 | 2014-05-23 |
Showing 20 of 31. Sign in to see all of them.
Diabetes Mellitus, Type 2 (2) · Essential Hypertension (2) · Infections (2) · Anemia (1) · Brain Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Cerebral Palsy (1) · Chronic Limb-Threatening Ischemia (1) · Colitis, Ulcerative (1) · Crohn Disease (1) · Cystic Fibrosis (1) · Dementia (1) · Dental Pulp Necrosis (1) · Enterocolitis, Necrotizing (1)
Kasiak Research Pvt. Ltd. (2) · Shenzhen Ausa Pharmed Co.,Ltd (2) · Alexandria University (1) · Anders Rosendal Korshøj (1) · Azad University of Medical Sciences (1) · CHU de Quebec-Universite Laval (1) · Charite University, Berlin, Germany (1) · Genexine, Inc. (1) · HELP Therapeutics Co., Ltd. (1) · Jinling Hospital, China (1) · Lasarettet i Enköping (1) · Manistee Partners (1) · Menno Veldman (1) · National Nutrition and Food Technology Institute (1) · New York Medical College (1)
China (5) · United States (5) · India (2) · Iran (2) · Austria (1) · Brazil (1) · Canada (1) · Denmark (1) · Egypt (1) · Germany (1) · Iraq (1) · Mexico (1) · Netherlands (1) · South Korea (1) · Spain (1)
Ali Reza Moaeidi, MD (1) · Amirali Hamidieh, MD (1) · Anahita Majma, MD (1) · Carmen Aceves, PhD (1) · Dinghua Yi, MD,PhD (1) · Dr. Arun B Bal, M.B.B.S.M.S. (1) · Dr. Ashish S Johari, M.B.B.S.M.S. (1) · Dr. Ashok A Mahashur, M.B.B.S.M.D. (1) · Dr. Kartik B Shah, M.B.B.S.M.D. (1) · Dr. Meena Kumar, M.B.B.S.M.S. (1) · Dr. Pratibha S Singhal, M.B.B.S.M.D. (1) · Dr.Sujeet K Rajan, M.B.B.S.M.D. (1) · Duane Wombolt, MD (1)
PMID 12529557, PMID 15037681, PMID 15922087, PMID 16108461, PMID 19416339, PMID 22818551, PMID 23607319, PMID 23705792, PMID 24100132, PMID 24909743, PMID 25104129, PMID 25593079, PMID 25927273, PMID 25986785, PMID 26340878, PMID 26376791, PMID 28901484, PMID 29530037, PMID 29906796, PMID 32151220, PMID 34129409, PMID 34362453, PMID 35351020, PMID 37433173, PMID 39745289, PMID 41324016, PMID 42156830, PMID 42861767
2023 (1)